EXACOMPTA CLAIREFONTAINE (EPA:EXAC) | WebDisclosure

Basculer en Français

10965	Companies
240075	Keywords
168812	Articles
129158	Press releases

Headlines Articles Press releases EXACOMPTA CLAIREFONTAINE

Home
Companies
EXACOMPTA CLAIREFONTAINE

REGULATED PRESS RELEASE

published on 09/24/2025 at 18:15, 11 months 16 days ago

Rapport semestriel 2025
BRIEF

published on 09/23/2025 at 18:20, 11 months 17 days ago

EXACOMPTA CLAIREFONTAINE Reports Decrease in H1 2025 Profits

Financial Results Market Challenges Revenue Decline Operating Income Management Changes
BRIEF

published on 09/23/2025 at 18:20, 11 months 17 days ago

EXACOMPTA CLAIREFONTAINE annonce une baisse de ses bénéfices au premier semestre 2025

Résultats Financiers Baisse Des Revenus Défis Du Marché Changements De Direction Résultat D'exploitation
REGULATED PRESS RELEASE

published on 09/23/2025 at 18:15, 11 months 17 days ago

Financial statements - 30 june 2025
EXACOMPTA CLAIREFONTAINE Board of Directors reviewed and approved Group financial statements for H1 2025 in Paris. Revenue down, operating income dropped, economic challenges noted

Financial Statements Revenue Operating Income Exacompta Clairefontaine Economic Conditions
BRIEF

published on 09/18/2025 at 18:20, 11 months 22 days ago

EXACOMPTA CLAIREFONTAINE 2025 half-year report: declining results

Half-year Results Turnover General Management Financial Debt Outlook 2025
BRIEF

published on 09/18/2025 at 18:20, 11 months 22 days ago

Bilan semestriel 2025 d'EXACOMPTA CLAIREFONTAINE : résultats en baisse

Chiffre D'affaires Résultats Semestriels Direction Générale Endettement Financier Perspectives 2025
REGULATED PRESS RELEASE

published on 09/18/2025 at 18:15, 11 months 22 days ago

Rapport semestriel 2025
Le conseil d'administration d'EXACOMPTA CLAIREFONTAINE arrête les comptes du 1er semestre 2025, marquant une baisse des résultats. Changement majeur aux postes de direction

Conseil D'administration Baisse Direction Exacompta Clairefontaine Comptes
REGULATED PRESS RELEASE

published on 05/13/2025 at 18:11, 1 year 3 months ago

DPEF - non financial performance declaration 2024
REGULATED PRESS RELEASE

published on 05/13/2025 at 18:10, 1 year 3 months ago

Annual report 2024
REGULATED PRESS RELEASE

published on 04/28/2025 at 18:10, 1 year 4 months ago

Rapport annuel 2024 - DPEF

Accesswire

Published on 09/11/2026 at 15:00, 27 minutes ago

Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 57 minutes ago

AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 13:58, 1 hour 29 minutes ago

BlackBerry Radar Advances Asset Intelligence for Transportation
Published on 09/11/2026 at 13:00, 2 hours 27 minutes ago

Silver Tiger Intersects 2.1 Metres of 7.72 Kilograms Per Tonne Silver Equivalent in the Caleigh Vein Including 0.53 Metres of 29.62 Kilograms
Published on 09/11/2026 at 04:00, 11 hours 27 minutes ago

Torq Announces Debt Settlement and Corporate Update

View all ACCESSWIRE

EQS Group

Published on 09/11/2026 at 15:17, 10 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 09/11/2026 at 14:35, 52 minutes ago

EQS-Adhoc: Österreichische Post AG: AUSTRIAN POST REACHES AGREEMENT WITH THE REPUBLIC OF AUSTRIA TO PAY COMPENSATION FOR SOCIAL CONTRIBUTIONS RELATING TO CIVIL SERVANTS FOR THE YEARS 1996 TO 2008
Published on 09/11/2026 at 14:25, 1 hour 2 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 09/11/2026 at 14:21, 1 hour 6 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 09/11/2026 at 14:11, 1 hour 16 minutes ago

Custodian Property Income REIT plc: Share Buyback

Les Echos

Published on 09/11/2026 at 07:00, 8 hours 27 minutes ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 8 hours 27 minutes ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 8 hours 27 minutes ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 8 hours 27 minutes ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 19 hours 57 minutes ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE